# Neuro-Ophthalmology * **Definition:** A subspecialty of ophthalmology that focuses on the relationship between the nervous system and the eyes. * **Taxonomy:** Specialties / Neuro-Ophthalmology ## News * Selected news on the topic of **Neuro-Ophthalmology**, for healthcare technology leaders * 3.2K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/24/2025 | [**769 - Healthcare IT News**](https://www.healthcareitnews.com/news%20/84546?page=768) | [[Healthcare IT News]] | | 2/27/2025 | [**NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of ... - FirstWord Pharma**](https://firstwordpharma.com/story/5938677) | [[FirstWord PHARMA]] | | 12/16/2024 | [**Federal funding boosts effort to make eye transplants a reality**](https://www.news-medical.net/news/20241216/Federal-funding-boosts-effort-to-make-eye-transplants-a-reality.aspx) | [[News Medical Net]] | | 12/11/2024 | [**Do AI Diagnostics have a role in telemedicine? What does this mean for healthcare equity?**](https://www.healthtechmagazines.com/do-ai-diagnostics-have-a-role-in-telemedicine-what-does-this-mean-for-healthcare-equity/) | [[Health Tech Magazines]] | | 11/22/2024 | [**North America's Optometry Software Market to Grow by USD 576.62 Million (2024-2028 ...**](https://www.prnewswire.com/news-releases/north-americas-optometry-software-market-to-grow-by-usd-576-62-million-2024-2028-driven-by-rising-ophthalmic-disease-cases-ai-redefining-market-landscape---technavio-302313504.html) | [[PR Newswire]] | | 11/12/2024 | [**Digital health technologies play a transformative role in diabetes management and prevention**](https://www.news-medical.net/news/20241112/Digital-health-technologies-play-a-transformative-role-in-diabetes-management-and-prevention.aspx) | [[News Medical Net]] | | 11/1/2024 | [**Ferrum Health Raises $16M in Series A Funding to Unlock AI Adoption in Healthcare**](https://www.healthcareittoday.com/2024/11/01/ferrum-health-raises-16m-in-series-a-funding-to-unlock-ai-adoption-in-healthcare/) | [[Healthcare IT Today]] | | 10/29/2024 | [**Asia-Pacific Digital Diagnostics Market Analysis and Forecast, 2023-2024 & 2033: Synergetic Partnership Opportunities with Hospitals and Diagnostic Centers Fuel Opportunities - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241029232642/en/Asia-Pacific-Digital-Diagnostics-Market-Analysis-and-Forecast-2023-2024-2033-Synergetic-Partnership-Opportunities-with-Hospitals-and-Diagnostic-Centers-Fuel-Opportunities---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/22/2024 | [**Pioneering Technological Developments Propel Regenerative Medicine Forward**](https://finance.yahoo.com/news/pioneering-technological-developments-propel-regenerative-080100178.html) | [[Yahoo Finance]] | | 10/18/2024 | [**12 threats stifling ASC success**](https://www.beckersasc.com/leadership/12-threats-stifling-asc-success.html) | [[Beckers ASC Review]] | | 10/8/2024 | [**Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography**](http://www.businesswire.com/news/home/20241008530546/en/Avania-Buys-Spanish-MedTech-CRO-Anagram-to-Enhance-Its-Core-CRO-Offering-in-a-New-European-Geography/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/7/2024 | [**AI is Redefining the Disposable Hospital Supplies Market, Projected to Grow by USD 24.5 Billion from 2024 to 2028 Amid Rising Hospitalizations**](https://www.prnewswire.com/news-releases/ai-is-redefining-the-disposable-hospital-supplies-market-projected-to-grow-by-usd-24-5-billion-from-2024-to-2028-amid-rising-hospitalizations-302267735.html) | [[PR Newswire]] | | 10/4/2024 | [**AI revolutionizes ophthalmology with oculomics for cardiovascular risk assessment**](https://www.news-medical.net/news/20241004/AI-revolutionizes-ophthalmology-with-oculomics-for-cardiovascular-risk-assessment.aspx) | [[News Medical Net]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/20/2024 | [**Ferrum Health Secures $16M for Vendor-Neutral AI Platform**](https://hitconsultant.net/2024/09/20/ferrum-health-secures-16m-for-vendor-neutral-ai-platform/) | [[HIT Consultant]] | | 9/20/2024 | [**Artificial Intelligence - Healthcare IT News**](https://www.healthcareitnews.com/taxonomy/term/7341/m89gsv6dzcjz.jsp/page/167?page=2) | [[Healthcare IT News]] | | 9/6/2024 | [**JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System**](http://www.businesswire.com/news/home/20240906392607/en/JuneBrain-Receives-MDIC-Advanced-Manufacturing-Clearing-House-Award-Selects-Compliance-Group-to-Implement-Siemens-Polarion-Design-Quality-System/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/12/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822114) | [[JAMA Network]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 8/8/2024 | [**Chutes & Ladders—Biogen CMO Maha Radhakrishnan joins Sofinnova**](https://www.fiercebiotech.com/biotech/chutes-ladders-biogen-cmo-maha-radhakrishnan-joins-sofinnova) | [[FierceBiotech]] | | 7/23/2024 | [**Mirror, Mirror: How Digital Twins Can Rescue Healthcare - Medscape**](https://www.medscape.com/viewarticle/mirror-mirror-how-digital-twins-can-rescue-healthcare-2024a1000das) | [[Medscape]] | | 6/28/2024 | [**297+ telehealth companies to know - 2024 - Becker's Hospital Review**](https://www.beckershospitalreview.com/lists/297-telehealth-companies-to-know-2024.html) | [[Beckers Hospital Review]] | | 6/25/2024 | [**Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031 - Exclusive Report by Meticulous Research®**](https://www.prnewswire.com/news-releases/research-antibodies-and-reagents-market-to-be-worth-6-77-billion-by-2031---exclusive-report-by-meticulous-research-302181579.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC)**: A collaborative group focused on advancing research and clinical trials in neuro-ophthalmology. - **American Academy of Ophthalmology (AAO)**: A professional organization that provides education, advocacy, and resources for ophthalmologists, including those specializing in neuro-ophthalmology. - **American Academy of Neurology (AAN)**: A professional association that supports neurologists and promotes research and education in neurology, including neuro-ophthalmology. - **Dr. Kimberly Gokoffski**: Neuro-ophthalmologist leading the THEIA project for eye transplantation techniques. - **MachineMD**: A company that developed the Neos™ system, which utilizes VR technology for neuro-ophthalmic assessments and has achieved ISO 13485:2016 certification. - **20/20NOW**: A leader in ocular telehealth, providing comprehensive eye exams and screenings through telehealth technology. - **OCLI Vision**: A leading ophthalmology practice in the U.S. that has expanded its team with specialists in diabetes-related eye health. - **Hamza Memon and Nicholas Panzo**: Students at Texas A&M University School of Engineering Medicine leading a neuro-ophthalmologic training project for NFL officials. - **EyeCare Partners LLC**: A large network of ophthalmologists and optometrists, focusing on enhancing patient experiences and operational efficiency through digital transformation. - **NeuroKaire**: A biotechnology company focused on precision medicine in psychiatry and neurology, specializing in pharmacogenetic testing. - **DelveInsight**: A market research firm that publishes reports on rare eye diseases, highlighting advancements in gene therapies and personalized medicine. - **Ring Therapeutics**: A biotechnology company specializing in gene therapy development, collaborating with A*STAR and the Singapore Eye Research Institute to advance treatments for ophthalmic diseases. - **G.N.S. neoLaser Ltd.**: A company focused on laser systems for medical applications, including endovenous laser ablation. - **Brain.Q**: A company focusing on AI technologies for tailored therapies in central nervous system conditions. - **Verana Health**: A healthcare technology company that serves as the exclusive data curation and analytics partner for the American Academy of Ophthalmology's IRIS Registry, focusing on enhancing real-world insights in ophthalmology. - **GenEdit, Inc.**: A biotechnology company focused on developing novel therapeutics for neurology and immunology. - **Firefly Neuroscience**: A partner of Zeto, providing Brain Network Analytics technology to enhance EEG platforms. - **A.R.C Laser GmbH**: A company specializing in innovative laser technologies for ophthalmic treatments. - **Brainomix**: A company developing AI-assisted tools for stroke care, improving decision support and patient outcomes. - **Mass General Brigham**: A healthcare system emphasizing innovation in therapeutics, digital transformation, and AI, particularly in neurology. ### Partnerships and Collaborations - **Collaboration between ophthalmology and neurology departments**: Many hospitals and research institutions are forming interdisciplinary teams to enhance the diagnosis and treatment of neuro-ophthalmic disorders. - **Industry partnerships for device development**: Collaborations between tech companies and healthcare providers to develop advanced imaging technologies and diagnostic tools for neuro-ophthalmology. - **Texas A&M University and NFL**: Collaboration to develop a neuro-ophthalmologic training curriculum for NFL officials. - **MachineMD with CSEM and Helbling Technik**: These partnerships support the development and clinical validation of the Neos™ system, enhancing its capabilities in neuro-ophthalmology. - **ViaLase, Inc. and John A. Moran Eye Center**: Research partnership to explore glaucoma treatment dynamics. - **USC Roski Eye Institute and THEIA project**: Collaboration to advance eye transplantation techniques. - **Ring Therapeutics and A*STAR/Singapore Eye Research Institute**: Strategic partnerships aimed at enhancing gene therapy development for ophthalmology and oncology. - **Brainomix and Brain.Q**: Collaboration to improve stroke care through innovative technologies addressing gaps in treatment and rehabilitation. - **Verana Health and American Academy of Ophthalmology**: Collaboration as the exclusive data partner for the IRIS Registry, the largest clinical data registry in medicine. - **Nihon Kohden and Ad-Tech Medical**: Nihon Kohden acquired a stake in NeuroAdvanced Corp. to enhance epilepsy diagnostics by integrating EEG expertise. - **PlatformQ Health**: Established the Medlive Advisory Board with experts in oncology, neurology, and cardiology to enhance medical education. - **Zeto and Firefly Neuroscience**: This partnership aims to enhance the distribution of Zeto's EEG headsets and integrate Firefly's analytics technology. - **MedWorld Advisors with A.R.C Laser and neoLaser**: Facilitated the acquisition and formation of the MedTech Laser Group to expand in the medical laser technology sector. - **NEC Thailand and Umong Municipality**: Implementing a digital healthcare platform aimed at improving elderly care and chronic disease management. - **Compliance Group and JuneBrain**: Partnership to implement a digital data-centric Design Quality System for medical device startups. - **Innovent Biologics and WeComput**: A strategic partnership aimed at enhancing AI for drug discovery, improving computational efficiency and reducing costs. - **AIIMS Delhi and GE HealthCare**: Collaborating to establish a hub focused on the development of healthcare AI solutions. - **St. Jude Lab and PreCheck Health Services**: Collaborating to integrate genetic testing into mainstream healthcare, enhancing patient care and operational efficiency. - **GenEdit, Inc. and various pharmaceutical companies**: GenEdit collaborates with pharmaceutical firms to develop targeted genetic medicines. - **Helix and Recursion Pharmaceuticals**: Partnering to enhance drug discovery efforts through access to clinico-genomic data. ### Innovations, Trends, and Initiatives - **Telemedicine in neuro-ophthalmology**: The adoption of telehealth services to provide remote consultations and follow-ups for patients with neuro-ophthalmic conditions. - **Neos™ System**: Utilizes a VR headset to gamify eye movement and pupillary response assessments, providing objective measurements for neuro-ophthalmic conditions in a clinical setting. - **AI in Neuro-Ophthalmology**: The integration of AI technologies is enhancing diagnostic accuracy and treatment personalization in neuro-ophthalmology. - **Neuro-Ophthalmologic Training Curriculum**: Developed for NFL officials to enhance decision-making skills using 2D game data for 3D simulations. - **Digital Health Technologies**: Advancements in digital health are transforming diabetes management and other chronic conditions, with implications for neuro-ophthalmology. - **Advancements in imaging technology**: Development of high-resolution imaging techniques, such as optical coherence tomography (OCT), to better visualize optic nerve and retinal conditions. - **THEIA Project**: Focuses on eye transplantation techniques, including nerve repair and preservation of donated eyes. - **AI in Ophthalmology**: Emerging field utilizing AI for detecting cardiovascular risk factors through fundus photography. - **AAV Gene Therapy**: Significant advancements in adeno-associated virus gene therapy are being made in ophthalmology and neurology, targeting hereditary retinal diseases and neurodegenerative disorders. - **Teleophthalmology**: The use of telemedicine in ophthalmology is expanding access to care, particularly in underserved areas. - **AI in Diagnostics**: AI-powered diagnostic tools are enhancing the accuracy of medical imaging and pathology, particularly in neuro-ophthalmology. - **Advanced Imaging Technologies**: Technologies such as Optical Coherence Tomography (OCT) and adaptive optics are providing high-resolution images for better monitoring of eye conditions. - **Telehealth Expansion**: The demand for telehealth services has surged, with companies like 20/20NOW leading in ocular telehealth solutions. - **Artificial Intelligence (AI) in diagnostics**: Utilization of AI algorithms to analyze imaging data and assist in diagnosing conditions such as optic neuritis and papilledema. - **Gene Therapy for Rare Eye Diseases**: Advancements in gene therapies are revolutionizing the treatment of conditions like Retinitis Pigmentosa. - **Remote Patient Monitoring**: Technological advancements are facilitating remote monitoring of neurological conditions, improving patient management. - **Qdata Retinitis Pigmentosa**: A new offering from Verana Health that utilizes real-world data to improve patient identification and insights into outcomes for inherited retinal diseases. - **Practice Insights**: A tool developed for IRIS Registry participants to help ophthalmologists monitor and optimize their practice operations against peer benchmarks. - **AI in Neurology**: Piramidal's AI model aims to streamline brain condition diagnostics, initially focusing on epilepsy and expanding to broader applications. ### Challenges and Concerns - **Access to Care**: Despite advancements, disparities in access to neuro-ophthalmology care remain a significant concern, particularly in underserved areas. - **Regulatory Hurdles**: Navigating the complexities of regulatory approvals for new therapies in the neuro-ophthalmology space. - **Access to specialized care**: Patients in rural or underserved areas may face challenges in accessing neuro-ophthalmology specialists, impacting timely diagnosis and treatment. - **High Costs of Technology**: The neuro-ophthalmology sector faces challenges related to the high costs of advanced imaging and monitoring technologies. - **Access to Treatments**: The need for effective diagnostic tools and treatments for neurological disorders, particularly in low-resource settings. - **Access to Advanced Tools**: There is a growing need for equitable access to advanced diagnostic tools in neurology, particularly for underserved populations. - **Market Competition**: Increased competition among biopharma companies for R&D investments and partnerships in neurology. - **Healthcare Disparities**: There are ongoing concerns about equitable access to eye care services, necessitating collaboration among healthcare providers. - **Aging Population**: The increasing number of elderly patients presents challenges in managing age-related eye diseases and healthcare access. - **Regulatory Compliance**: Ensuring that innovative medical devices like Neos™ meet stringent regulatory standards such as EU-MDR Class IIa certification. - **Integration into Clinical Practice**: The challenge of integrating new technologies into existing clinical workflows without disrupting patient care. - **Nursing Shortages and Overworked Staff**: Challenges faced by healthcare providers that Stryker aims to address through the integration of AI-assisted virtual care workflows. - **Regulatory Acceptance of AI**: The challenge of balancing innovation with safety and responsibility in the medical field, particularly regarding AI-driven clinical trials. - **Staffing Shortages**: Ongoing issues in staffing for ASCs, particularly in nursing and anesthesia, impacting operational efficiency. - **Data privacy and security**: Concerns regarding the protection of patient data, especially with the increased use of telemedicine and digital health records. - **Data Privacy and Security**: Concerns regarding the security of sensitive health information and the need for responsible AI usage in healthcare. - **Integration of technology**: The need for healthcare providers to adapt to new technologies and ensure interoperability between systems for effective patient care. - **AI Adoption in Healthcare**: Need for trustworthy AI models and overcoming challenges before clinical adoption. - **Regulatory Issues**: The evolving regulatory landscape for AI and digital health technologies poses challenges for implementation in clinical settings. - **Data Privacy**: The integration of AI in healthcare raises concerns about data collection, privacy, and the need for robust regulatory frameworks. ## Related Topics [[Ophthalmology]]; [[Neurology]]; [[Neurotology]]; [[Ocular Oncology]]; [[Glaucoma Ophthalmology]]